Surgalign Holdings Inc Quick Ratio (SRGA) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Surgalign Holdings Inc   (NASDAQ: SRGA)

Surgalign Holdings Inc 's Quick Ratio

SRGA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Surgalign Holdings Inc 's Cash & cash equivalent grew by 37.65 % in the Q1 2023 sequentially, while Current Liabilities decreased, this led to improvement in Surgalign Holdings Inc 's Quick Ratio to 1.12, above Surgalign Holdings Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 118 other companies have achieved higher Quick Ratio than Surgalign Holdings Inc in first quarter 2023. While Quick Ratio total ranking has improved so far during the Q1 2023 to 1756, from total ranking in the fourth quarter 2022 at 2104.

Explain Quick Ratio?
How much Cash & cash equivalents SRGA´s has?
What are SRGA´s Current Liabilities?




SRGA Quick Ratio (Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
Y / Y Current Liabilities Change -29.5 % -60.87 % -37.2 % -29.46 % -49.4 %
Y / Y Cash & cash equivalent Change -49.8 % -68.23 % -79.75 % -57.63 % -29.93 %
Quick Ratio MRQ 1.12 0.77 0.4 0.79 1.58
SRGA's Total Ranking # 1756 # 2104 # 3239 # 2129 # 1496
Seq. Current Liabilities Change -5.5 % -39.04 % -6.86 % 31.4 % -47.55 %
Seq. Cash & cash equivalent Change 37.65 % 17.7 % -52.82 % -34.32 % -12.89 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 119
Healthcare Sector # 724
Overall Market # 1756


Quick Ratio Statistics
High Average Low
1.79 0.77 0.01
(Sep 30 2020)   (Jun 30 2020)




Financial Statements
Surgalign Holdings Inc 's Current Liabilities $ 20 Millions Visit SRGA's Balance sheet
Surgalign Holdings Inc 's Cash & cash equivalent $ 22 Millions Visit SRGA's Balance sheet
Source of SRGA's Sales Visit SRGA's Sales by Geography


Cumulative Surgalign Holdings Inc 's Quick Ratio

SRGA's Quick Ratio for the trailling 12 Months

SRGA Quick Ratio

(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -40.62 % -44.32 % -20.08 % -8.66 % -54.83 %
Y / Y Cash & cash equivalent TTM Growth -64.93 % -58.78 % -43.28 % -29 % 13.53 %
Quick Ratio TTM 0.72 0.86 0.9 1.11 1.23
Total Ranking TTM # 4757 # 4522 # 4516 # 2089 # 4460
Seq. Current Liabilities TTM Growth -6.89 % -21.32 % -11.75 % -8.17 % -12.69 %
Seq. Cash & cash equivalent TTM Growth -21.36 % -25.15 % -28.15 % -17.09 % -7.55 %


On the trailing twelve months basis In spite of the year on year decrease in SRGA's Current Liabilities to $19.98 millions, cumulative Quick Ratio to 0.72 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 248 other companies have achieved higher Quick Ratio than Surgalign Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2022 from 4522 to 4757.

Explain Quick Ratio?
How much Cash & cash equivalents SRGA´s has?
What are SRGA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 249
Healthcare Sector # 1194
Within the Market # 4757


trailing twelve months Quick Ratio Statistics
High Average Low
1.3 0.6 0.02
(Jun 30 2021)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Orthopediatrics Corp  3.06 $ 107.730  Millions$ 35.218  Millions
Icecure Medical Ltd  3.03 $ 11.062  Millions$ 3.648  Millions
Neuroone Medical Technologies Corp  2.97 $ 4.598  Millions$ 1.550  Millions
Nuwellis Inc   2.94 $ 12.090  Millions$ 4.107  Millions
Shockwave Medical Inc   2.94 $ 416.861  Millions$ 141.998  Millions
Catheter Precision Inc   2.74 $ 12.218  Millions$ 4.453  Millions
Irhythm Holdings Inc   2.74 $ 176.337  Millions$ 64.385  Millions
Bone Biologics Corporation  2.72 $ 6.188  Millions$ 2.279  Millions
Koru Medical Systems Inc   2.70 $ 12.225  Millions$ 4.524  Millions
Milestone Scientific Inc   2.53 $ 6.708  Millions$ 2.653  Millions
Harvard Apparatus Regenerative Technology Inc   2.47 $ 3.269  Millions$ 1.326  Millions
Sintx Technologies Inc   2.46 $ 12.626  Millions$ 5.126  Millions
Dariohealth Corp   2.46 $ 43.318  Millions$ 17.617  Millions
Myomo Inc   2.35 $ 9.264  Millions$ 3.934  Millions
Atricure Inc   2.17 $ 135.860  Millions$ 62.471  Millions
Alphatec Holdings Inc   2.12 $ 116.698  Millions$ 55.138  Millions
Tela Bio Inc   2.09 $ 30.124  Millions$ 14.406  Millions
Electrocore Inc   2.06 $ 11.908  Millions$ 5.771  Millions
Orasure Technologies Inc  2.04 $ 112.372  Millions$ 55.123  Millions
Motus Gi Holdings Inc   1.98 $ 8.648  Millions$ 4.378  Millions
Nuo Therapeutics Inc   1.93 $ 1.250  Millions$ 0.649  Millions
Soleno Therapeutics Inc  1.88 $ 7.874  Millions$ 4.191  Millions
Axogen inc   1.88 $ 37.867  Millions$ 20.188  Millions
Warby Parker Inc   1.84 $ 204.261  Millions$ 111.039  Millions
Cytosorbents Corporation  1.83 $ 19.048  Millions$ 10.436  Millions
Delcath Systems Inc   1.82 $ 24.272  Millions$ 13.318  Millions
Stereotaxis Inc   1.80 $ 25.664  Millions$ 14.269  Millions
Tenon Medical Inc   1.79 $ 4.916  Millions$ 2.752  Millions
Vapotherm Inc   1.74 $ 25.713  Millions$ 14.784  Millions
Globus Medical Inc   1.71 $ 286.685  Millions$ 167.547  Millions

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.